Skip to Main Content
Corporate

NIPT Test

General Information About the Test

The NIPT (Non-Invasive Prenatal Test) is a next-generation screening technology with a 99% accuracy rate, developed to evaluate the genetic health of the baby in the womb. This method, which involves isolating and sequencing tiny DNA fragments (cffDNA) belonging to the baby (placenta) that circulate freely in the mother's blood, detects chromosomal disorders such as Trisomy 21 (Down Syndrome), Trisomy 18, and Trisomy 13 via a simple blood test, without the use of an amniocentesis needle.

Test Process and Preparation

Administration and processes of the NIPT (Cell-free DNA) test.

Double or quadruple tests only make a statistical probability calculation indirectly (via hormones) and have an accuracy rate of around 80-85%. Because NIPT directly examines the baby's DNA, its accuracy rate is over 99%.

It is primarily recommended for expectant mothers aged 35 and over, those with a history of genetic anomalies in previous pregnancies or their families, and women identified as high risk in double/quadruple screening tests.

NIPT is not a diagnostic test, but a very powerful screening test. If the NIPT result is high-risk (positive), as per medical procedure, it is mandatory to definitively diagnose (confirm) this condition via Amniocentesis (fluid extraction) before terminating the pregnancy.

The information on this page is for informational purposes only. The results of medical tests must be evaluated by specialist physicians.

You can find all the information regarding your treatment and hospital stay process in this section.

Patient Visits

Details

Nursing Services

Details

Patient Admission

Details

Your Hospital Stay

Details
E-Appointment
E-Consultation
Contact Us
App

Çakırtepe Hospital

Mobil Uygulama ★★★★★